People · Operator
Named in public records as an officer, director or promoter · active 2018–2026 · Other Technology, Biotechnology, Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mawson Infrastructure Group Inc. | — | Other Technology | Series B | $40.3M | $4.4M | 2018 |
| Entera Bio Ltd. | — | Biotechnology | Series A | $22.2M | $44.8M | 2023 |
| IceCure Medical Ltd. | Director | Biotechnology | Series B | $16.5M | $50.2M | 2026 |
| IceCure Medical Ltd. | — | Biotechnology | Seed | $8.0M | $7.4M | 2026 |
| INNOCAN PHARMA Corp | — | Pharmaceuticals | Series A | $6.6M | $115.0M | 2021 |
| IR-Med, Inc. | — | Other Health Care | Seed | $5.4M | $36.9M | 2022 |
Ron Mayron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ron Mayron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yoram Drucker | 2 | 6 |
| Merav Nir Dotan | 2 | 2 |
| Sharon Levita | 2 | 2 |
| Vincent Chun Hung Chan | 2 | 2 |
| Yang Huang | 2 | 2 |
| Shay Levav | 2 | 2 |
| Yonatan Malca | 2 | 2 |
| Tlalit Bussi Tel-Tzure | 2 | 2 |
| Eyal Shamir | 2 | 2 |
| Shad Good | 2 | 2 |
| GREG MARTIN | 1 | 12 |
| DAVID LAZAR | 1 | 5 |
| Mark Sieczkarek | 1 | 5 |
| Adam Gridley | 1 | 4 |
| Faith Charles | 1 | 4 |
| Doron Birger | 1 | 3 |
| Sean Ellis | 1 | 3 |
| Yaacov Goldman | 1 | 3 |
| Doron Cohen | 1 | 3 |
| Michael Hughes | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.